The digital pathology systems are getting very popular worldwide attributed mainly to its capability to efficiently recognize and validate new drug candidates, create molecular treatments and measure toxicology in the new drug and classify patients for the treatment. Whole slide imaging (WSI) is the most widely adopted technology for the digital pathology attributed to its advantages such as Z-axis scanning of the slides, enhanced regulation of the digital images in shorter time span, and multiple magnification. The increasing use of digital pathology in academics due to dynamic telepathology and real time imaging and controlled movement, are expected to drive the digital pathology market in coming years.
[b]Explore more about “global digital pathology market” at:[/b] https://www.psmarketresearch.com/market-analysis/digital-pathology-market
Based on the various products the global digital pathology market can be broadly classified as scanners, analytics, storage and communication or delivery modes. Based on the different application of digital pathology the global digital pathology market can be segmented as human pathology (including Pharmaceutical & Biotechnology Companies, Training and Education and others), animal pathology (including pharmaceutical & biotechnology companies, academic & government research institutes, and contract research organizations).
[b]Request TOC at:[/b] https://www.psmarketresearch.com/market-analysis/Digital-Pathology-Market/toc-sample
North America was the largest market for digital pathology market in 2014. The market dominance of North America is attributed the presence of high adoption of advanced and sophisticated medical technology in the region. It is then followed by Europe; the large population of baby boomers and increasing trend towards companion diagnostics is one of the most dominant factors driving the digital pathology market in this region. Asia-Pacific and Latin America are the fasted growing market for digital pathology attributed to the rising prevalence of cancer in addition with easy availability of consultation enabled by digital pathology. Country wise the U.S. and Canada are the largest market of digital pathology in North America. Germany, the U.K., France, and Italy are some of the major digital pathology market in Europe, China, India, and Japan is a major digital pathology market in Asia Pacific.
[b]Browse Other Related Report at:[/b] https://www.psmarketresearch.com/industry-report/medical-devices
Some of the major players operating in the global digital pathology market include, 3dhistech Ltd., Aurora Interactive Ltd., Definiens AG, Hamamatsu Photonics K.K., Indica Labs, Inc., Leica Biosystems, Gmbh, Mikroscan Technologies, Inc., Objective Pathology Services, Ltd., Xifin, Inc., Pixcelldata, Ltd., Ventana Medical Systems, Inc., Apollo Pacs, Inc., Corista LLC, Digipath, Inc., Huron Technologies International, Inc., Kanteron Systems, Ligolab, LLC , Nikon Instruments, Inc., Omnyx, LLC, Pathxl, Ltd., Sunquest Information Systems, Inc., and Visiopharm.